Since our founding in 2010, CGT Global has pursued our mission to transform healthcare as we accelerate cell and gene therapy research and clinical trials, streamline the commercialization of new treatments, and map the last mile to patient access to these life-changing remedies. By innovating each stage in the cycle; development, commercialization, and delivery, we reduce the overall cost of the care and multiply access points so that millions can receive cutting edge, life-saving gene and cell therapies.

Description
Neutrophils are phagocytic granulocytes that spend most of their lives circulating in peripheral blood. Within the bloodstream they account for approximately 60% of all leukocytes. Once stimulated by a sequence of inflammatory events, neutrophils are one of the first of the inflammatory cells to migrate to areas of infection or tissue injury where they engulf bacteria, other microorganisms, and microscopic particles.
Additional information
Anticoagulant | |
---|---|
Format | |
Grade | |
Species | |
Cell and Tissue Source | |
Disease State | |
Donor Attributes |